Kalinka, E.Bondarenko, I.Gogishvili, M.Melkadze, T.Baramidze, A.Sezer, A.Makharadze, T.2024-05-192024-05-1920231556-08641556-1380https://hdl.handle.net/20.500.12713/5973[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keywords]First-line cemiplimab for locally advanced non-small cell lung cancer: Updated subgroup analyses from EMPOWER-Lung 1 and EMPOWER-Lung 3Conference Object184S106S106WOS:000995007600116N/A